Multi-target-directed ligands to combat neurodegenerative diseases; Role of molecular dynamics and related methods in drug discovery; Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers; Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action; Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview; QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development; 3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β …; Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease; Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds; Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania; Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush; Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition; A small molecule targeting the multifactorial nature of Alzheimer's disease; A catalytically silent FAAH-1 variant drives anandamide transport in neurons; SAR of 9-amino-1, 2, 3, 4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues; Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis; Single-molecule pulling simulations can discern active from inactive enzyme inhibitors; Multitarget drug discovery and polypharmacology; Structural basis of cis-and trans-combretastatin binding to tubulin; Organocatalytic asymmetric conjugate addition of 1, 3‐dicarbonyl compounds to maleimides
